Milestone Scientific Stock Debt To Equity
| MLSS Stock | USD 1.09 0.01 0.93% |
Fundamental analysis of Milestone Scientific allows traders to better anticipate movements in Milestone Scientific's stock price by examining its financial health and performance throughout various phases of its business cycle.
Milestone | Build AI portfolio with Milestone Stock |
Milestone Scientific Company Debt To Equity Analysis
Milestone Scientific's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Current Milestone Scientific Debt To Equity | 0.05 % |
Most of Milestone Scientific's fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Milestone Scientific is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
| Competition |
According to the company disclosure, Milestone Scientific has a Debt To Equity of 0.046%. This is 99.91% lower than that of the Health Care Equipment & Supplies sector and 99.92% lower than that of the Health Care industry. The debt to equity for all United States stocks is 99.91% higher than that of the company.
Milestone Debt To Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Milestone Scientific's direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Milestone Scientific could also be used in its relative valuation, which is a method of valuing Milestone Scientific by comparing valuation metrics of similar companies.Milestone Scientific is currently under evaluation in debt to equity category among its peers.
Milestone Fundamentals
| Return On Equity | -0.68 | ||||
| Return On Asset | -0.4 | ||||
| Profit Margin | (0.55) % | ||||
| Operating Margin | (1.01) % | ||||
| Current Valuation | 82.52 M | ||||
| Shares Outstanding | 78.38 M | ||||
| Shares Owned By Insiders | 22.75 % | ||||
| Shares Owned By Institutions | 5.66 % | ||||
| Number Of Shares Shorted | 146.15 K | ||||
| Price To Earning | (6.39) X | ||||
| Price To Book | 12.36 X | ||||
| Price To Sales | 9.81 X | ||||
| Revenue | 8.63 M | ||||
| Gross Profit | 6.43 M | ||||
| EBITDA | (6.72 M) | ||||
| Net Income | (4.71 M) | ||||
| Cash And Equivalents | 9.81 M | ||||
| Cash Per Share | 0.14 X | ||||
| Total Debt | 349.05 K | ||||
| Debt To Equity | 0.05 % | ||||
| Current Ratio | 3.95 X | ||||
| Book Value Per Share | 0.07 X | ||||
| Cash Flow From Operations | (2.92 M) | ||||
| Short Ratio | 2.43 X | ||||
| Earnings Per Share | (0.06) X | ||||
| Target Price | 2.13 | ||||
| Number Of Employees | 17 | ||||
| Beta | 1.13 | ||||
| Market Capitalization | 85.43 M | ||||
| Total Asset | 9.8 M | ||||
| Retained Earnings | (128.05 M) | ||||
| Working Capital | 5.54 M | ||||
| Current Asset | 10.74 M | ||||
| Current Liabilities | 4.4 M | ||||
| Net Asset | 9.8 M |
About Milestone Scientific Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Milestone Scientific's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Milestone Scientific using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Milestone Scientific based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Milestone Stock Analysis
When running Milestone Scientific's price analysis, check to measure Milestone Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Milestone Scientific is operating at the current time. Most of Milestone Scientific's value examination focuses on studying past and present price action to predict the probability of Milestone Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Milestone Scientific's price. Additionally, you may evaluate how the addition of Milestone Scientific to your portfolios can decrease your overall portfolio volatility.